Regulatorische Updates

Regulatory updates exempt pharmacies from business registration and provide a checklist, allowing pharmacy managers to act as product managers and outsource splitting without dedicated facilities.

A relay demonstration by regional pharmacist societies and the Korean Pharmaceutical Association continued for the 341st day, urging the government and National Assembly to address longstanding Han‑Yak‑Sa concerns.

The Korean government plans to broaden pharmacy information provided to private telemedicine services from simple stock status to detailed purchase and dispensing quantities, prompting industry worries over data exposure.

The Dongjak‑gu Pharmacy Association warned that expanding prescription drug delivery for telemedicine could worsen health‑insurance finances and increase drug misuse, calling for an immediate stop.

보건복지부가 2026년 혁신형 제약기업 신규·재인증을 위한 세부 평가기준을 전면 확정 공고했습니다.

The Ministry of Health and Welfare announced on Aug 24 2026 the promotion of Kim Min‑Jung to Section Chief of the Medical Information Policy Division.

Yoon Sun‑hee presented Japan’s pharmacist‑led home medication systems and their relevance to Korea’s new integrated care law.

The Health Society for the Public (Geonyak) has called on the government to halt plans to extend remote prescription drug delivery to all patients, warning it could compromise appropriate use and medication safety.

The Seoul Jung‑gu Pharmacists Association strongly protested the government’s plan to expand the list of approved emergency medicines and to broaden prescription drug delivery for all telemedicine patients, calling the measures irresponsible.

The Korean MFDS announced ten health‑functional food ingredients, such as bilberry extract, will undergo a regular re‑assessment in 2027.

Gyeonggi regional pharmacy chairs reject the government’s plan to broaden home delivery of medicines and OTC items, citing conflict with the Constitutional Court ruling.

The Ministry of Health and Welfare will discuss expanding drug delivery to all telemedicine patients and forming a public‑private council to address pharmacist duties in a non‑face‑to‑face setting.